Loading peptide library…
PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Explore research-backed breakdowns of each peptide — mechanisms, benefits, typical protocols, and notable studies. Search or filter by category to find what you need.
32 peptides
A synthetic peptide fragment derived from a protein found in gastric juice, studied for its broad tissue-healing and cytoprotective effects. Popular in research for tendon, ligament, muscle, and gut repair.
A synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide that regulates cell migration and tissue repair. Researched for recovery, flexibility, and wound healing.
The only human cathelicidin antimicrobial peptide, central to innate immunity. Studied for antimicrobial, immunomodulatory, and wound-healing properties.
A combination of BPC-157 and TB-500 frequently used together in recovery research to pair localized angiogenic healing with systemic cell-migration and tissue-remodeling effects.
ARA-290 (Cibinetide) is an 11-amino-acid peptide derived from erythropoietin, studied for nerve repair and reducing neuropathic pain without affecting red blood cells.
B7-33 is a single-chain peptide analog of the hormone relaxin-2, engineered to retain its anti-fibrotic and vasodilatory actions while resisting rapid breakdown. It is studied chiefly for reducing scar tissue (fibrosis) in heart, lung, and kidney models.
GHK is a naturally occurring human tripeptide (glycyl-L-histidyl-L-lysine) studied for skin remodeling, wound healing, and tissue regeneration. The copper-free 'basic' form is the parent peptide that readily binds copper in tissue.
KPV is a tripeptide derived from the C-terminus of alpha-MSH that exerts anti-inflammatory effects without pigmentary activity. It is studied for gut inflammation, wound healing, and skin conditions.
SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide studied for protecting mitochondrial function in conditions involving oxidative stress and energy failure. It has been investigated clinically for mitochondrial myopathy and heart and kidney disease.
ABP-7 is a research peptide marketed as an analog within the alpha-MSH / melanocortin family, studied for its potential anti-inflammatory and tissue-protective signaling.
PTD-DBM is a cell-permeable peptide studied in hair-loss research for its ability to activate Wnt/beta-catenin signaling and promote hair follicle neogenesis.
CardioCytogen is a proprietary short-peptide bioregulator marketed for cardiovascular and heart-tissue support. It is sold as a research chemical with limited published characterization.
Cortexin is a polypeptide complex extracted from cerebral cortex tissue, used clinically in Russia and several other countries as a neuroprotective and nootropic agent. In Western markets it is sold as a research chemical. (Cortexin is a registered polypeptide drug in some countries; presented here for educational/research reference only, not as medical guidance.)
Dermorphin is a naturally occurring opioid heptapeptide originally isolated from the skin of South American Phyllomedusa frogs that acts as an extremely potent and selective mu-opioid receptor agonist.
GLOW is a combination research blend of BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu studied for tissue repair, recovery, and skin and connective-tissue health. Each component is an unapproved research peptide.
GLOW 2 is a second-generation recovery and skin research blend built around BPC-157, TB-500, and GHK-Cu, typically at adjusted ratios or concentrations. The components are unapproved research peptides.
KLOW extends the GLOW concept by adding the anti-inflammatory tripeptide KPV to BPC-157, TB-500, and GHK-Cu. It is studied for recovery, gut and tissue healing, and skin quality, and its components are unapproved research peptides.
A multi-component research blend combining the cytoprotective peptide BPC-157 with the anti-inflammatory tripeptide KPV plus fatty-acid mediators aimed at gastrointestinal mucosal repair. It is studied for its combined effects on gut-barrier integrity and local inflammation.
A research blend pairing a stabilized arginate salt of BPC-157 with an active fragment of Thymosin Beta-4 to target soft-tissue and musculoskeletal repair. It is studied for accelerated wound healing and recovery.
A research blend pairing the cytoprotective peptide BPC-157 with the actin-binding fragment 17-23 of Thymosin Beta-4 (TB-500). It is studied for soft-tissue repair, angiogenesis, and recovery.
A research blend combining the long-acting growth factor IGF-1 LR3 with the cytoprotective peptide BPC-157 to support anabolic growth and tissue repair. It is studied for muscle growth, recovery, and injury healing.
N-Acetyl Semax Amidate is a stabilized analog of the ACTH(4-10)-derived nootropic peptide Semax, modified for durability and intranasal use. It is studied for cognition, focus, and neuroprotection.
TB-500 Fragment 17-23 is a short peptide corresponding to the actin-binding region of thymosin beta-4, studied for tissue repair and regeneration. It represents the core bioactive sequence often credited with TB-500's healing effects.
TB-500 Fragment 1-4 is the N-terminal tetrapeptide (Ac-SDKP) of thymosin beta-4, studied for anti-fibrotic and tissue-protective effects. This fragment is distinct from the actin-binding region and is associated with regulation of fibrosis and inflammation.
Tripeptide-29 is a collagen-biomimetic tripeptide used in topical skincare to signal fibroblasts toward collagen production. It is studied for firmness, elasticity, and overall skin matrix support.
Vesugen is a short tripeptide bioregulator studied for support of the vascular system and blood-vessel wall integrity. It is part of the Khavinson peptide family aimed at tissue-specific regulation.
Vialox is a topical pentapeptide marketed as a needle-free muscle-relaxing cosmetic ingredient. It is studied for softening expression lines by reducing local muscle contraction at the skin surface.
VIP (vasoactive intestinal peptide) is a 28-amino-acid signaling peptide with vasodilatory, anti-inflammatory, and immunoregulatory actions. It is studied intranasally in protocols for chronic inflammatory and biotoxin-related illness.
An N-acetylated analog of larazotide acetate, an octapeptide studied as a tight-junction regulator intended to reduce intestinal permeability (leaky gut). The N-acetyl modification is marketed to improve enzymatic stability of the parent peptide.
Teriparatide is the recombinant N-terminal 1-34 fragment of human parathyroid hormone and an FDA-approved anabolic therapy for osteoporosis. It builds bone when given as a once-daily intermittent dose.
Erythropoietin (EPO) is a glycoprotein hormone, produced mainly by the kidneys, that stimulates red blood cell production. Recombinant EPO is an established clinical therapy for anemia.
Human Relaxin-2 is a peptide hormone with vasodilatory and anti-fibrotic properties, also developed clinically as serelaxin. It is studied for cardiovascular and tissue-remodeling research.